Trailblazing Study Shows Early CGP Leads to Better Precision Treatments
A large, multiyear study conducted by Illumina, Providence, and Microsoft Research has shown that a comprehensive genomic profiling (CGP) panel, which can assess more than 500 genetic variations in tumors, is a powerful tool to direct patients to advanced precision therapy.
Elanco Celebrates Global Day of Purpose
Elanco’s Global Day of Purpose (GDOP) is our annual capstone employee volunteerism event, which has evolved from a single day to become a popular year-round initiative including dozens of individual and group volunteer events around the world.
Subscribe to